WestView-backed Dark Horse Consulting completed the acquisition of BioTechLogic.

WestView-backed Dark Horse Consulting, a longstanding global leader in strategic and operational consulting in the field of cell and gene therapy, completed the acquisition of BioTechLogic, a recognized forerunner in technical operations, manufacturing, quality, and regulatory CMC consulting. Financial terms were not disclosed. "We are thrilled to welcome BioTechLogic to the Dark Horse Consulting Group. This acquisition allows us to extend our client base into the domains of traditional biologics and vaccine development while further optimizing efficiencies of cost, timeline, and resources for our CGT customers. We are excited to combine DHC’s ‘white glove’ strategic advisory services with BioTechLogic’s significant operational expertise and technical services,” Anthony Davies, DHC Founder and CEO.